Synonyms Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, recurrent cutaneous squamous cell carcinoma of the head and neck |
Introduction The reemergence of cutaneous squamous cell carcinoma of the head and neck after a period of remission. |
Target |
Mechanism EGFR antagonists |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date25 Sep 2020 |
Target |
Mechanism PD-1 inhibitors |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date04 Sep 2014 |
Target |
Mechanism EGFR antagonists |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseNDA/BLA |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date09 Jan 2025 |
Sponsor / Collaborator |
Start Date01 Jan 2025 |
Sponsor / Collaborator Emory University [+2] |
Start Date01 Dec 2024 |
Sponsor / Collaborator |